Dementia screening for the hearing impaired

Published Date: 08 Mar 2023

Researchers at the University of Queensland have adapted a test used around the world to screen people with dementia and Alzheimer's disease to make it suitable for people with hearing loss.

Read Full News

Latest News

Novartis Pauses Trials Of Experimental Cell Therapy After Three Deaths

Novartis said on Tuesday it paused eight clinical trials of an experimental cell therapy, called rap-cel, targeting autoimmune and neurological disorders in late ⁠August,...

Cerebral Palsy Linked to Gaps in Gynecologic Care

Cerebral palsy in women is associated with markedly reduced odds of receiving routine preventive gynecologic care.

Borderline Personality: Evidence Has Evolved. Care Hasn’t

A quiet revolution in borderline personality disorder has exposed a disconnect: Treatment works, recovery is possible, yet outdated assumptions continue to shape clinical care.

New Stroke Rehab Guideline Calls for Earlier, Broader Care

The first update to adult stroke rehabilitation and recovery guidelines in a decade emphasizes early, individualized care addressing physical, cognitive, communication, and mental health needs.

Exercise May Prevent Memory Loss From Sleep Restriction

A 30-minute moderate-intensity exercise session before bedtime may protect long-term memory from cognitive impairment related to restricted sleep, a trial shows.

Duchenne Drug Gets Three-month FDA Extension After New Data Submission

Capricor Therapeutics said on Monday the U.S. Food and Drug Administration had extended the review period for ⁠its experimental cell therapy for Duchenne muscular dystrophy...

Todays Updates

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

Todays Updates

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

Latest News

Novartis said on Tuesday it paused eight clinical trials of an experimental cell therapy, called rap-cel, targeting autoimmune and neurological disorders in late ⁠August,...

Cerebral palsy in women is associated with markedly reduced odds of receiving routine preventive gynecologic care.

A quiet revolution in borderline personality disorder has exposed a disconnect: Treatment works, recovery is possible, yet outdated assumptions continue to shape clinical care.

The first update to adult stroke rehabilitation and recovery guidelines in a decade emphasizes early, individualized care addressing physical, cognitive, communication, and mental health needs.

A 30-minute moderate-intensity exercise session before bedtime may protect long-term memory from cognitive impairment related to restricted sleep, a trial shows.

Capricor Therapeutics said on Monday the U.S. Food and Drug Administration had extended the review period for ⁠its experimental cell therapy for Duchenne muscular dystrophy...

News All Time

Superagers' Exceptional Memory Can't Be Explained by Genes Alone, Study Finds

Inherited Alzheimer's risk didn't differ between superagers and cognitively average older adults

Diarrhea Bug Outbreak Hits 4 More States; Fauci to Testify; Doc Dies in House Fire

Health news and commentary gathered by MedPage Today staff

Hold Off on JAK Inhibitors in Rheumatoid Arthritis Until After Shingles Vax?

Good things come to those who wait -- and to those who don't wait

FDA Approves Tylenol With Naproxen Combination

First OTC fixed-dose combination product to pair acetaminophen with naproxen sodium

FDA Panel Finds a Peptide It Doesn't Like

Over 2-day meeting, six of seven peptides are recommended for adding to bulk compounding list

Brain Worm Culprit in Woman's Hallucinations, Incoherent Speech

MRI uncovers neurocysticercosis in a 52-year-old woman

First-in-Class Drug for ADHD Wins FDA Approval

Triple reuptake inhibitor centanafadine is indicated for patients ages 6 years and older

FDA Scientists Raise Questions About Duchenne Drug

Agency says deramiocel did not meet phase III trial endpoints, contrary to reported data

Sugar Rationing in Early Life Linked to Lower Dementia Risk Decades Later

Long-term study looks at what happened when sugar was scarce

Feds Delay Autism Meeting; Wildfire Smoke and Migraine; Mortality and MS

News and commentary from the world of neurology and neuroscience

FDA Committee Votes Down Duchenne Drug

Agency staff and drug developer disagree on endpoints

Fauci Successor Imminent; CDC Expands Outbreak List; Pesticides Linked to ALS

Health news and commentary gathered by MedPage Today staff

Alzheimer's Paper Retracted; MS Before Epstein-Barr Infection; Brain Aging Map

News and commentary from the world of neurology and neuroscience

FDA Approves First-in-Class Narcolepsy Drug

Oveporexton treats more than symptoms, restores orexin signaling

Pet Hamsters Linked to Rare Brain Disorder

Exposure was associated with autoimmune cerebellar ataxia in a hospital case-control study

Trump Issues Controversial Order on Vaccines, Suggests Autism Link

Order calls for MMR vaccine to be split up, given at separate medical appointments

Recommended News For You

Small-Town Patients Face Big Hurdles as Rural Hospitals Cut Cancer Care

New methods show how fast breast cancers grow and how surgery delays affect cancer staging

Study reveals crucial gaps in oral cancer awareness in Middle East and North Africa

Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts

Study indicates that exercise can help colon cancer survivors live as long as matched individuals

AI tool automates liver tumor detection and monitoring

Indoor hydroponic gardening can improve mental health and quality of life for cancer patients

Recommended Articles For You

CEUS in Endometrial Cancer: A Tool for Early Myometrial Infiltration Detection 

Early Recognition of Immune-Related Adverse Events During Cancer Therapy 

Hematopoietic Niche Reconditioning Strategies in Blood Disorders 

Tumor Ecosystem Activity Biomarkers in Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The need for more Latinx participants in Alzheimer's trials is urgent.

2.

Study reveals crucial gaps in oral cancer awareness in Middle East and North Africa

3.

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

4.

In breast-conserving surgery, is micro-CT a useful tool for determining tumor margins?

5.

Study offers clearer picture of childhood brain tumor survival

1.

Revolutionizing Cancer Care: The Promise of Early Detection and Biomarkers

2.

The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment

3.

Comprehensive Standards in Oncology for Modern Medicine

4.

Cardio-Oncology: Managing Heart Failure in Survivors of Cancer

5.

Practical Standards in Hematology for Healthcare Excellence

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

3.

Efficient Management of First line ALK-rearranged NSCLC - Part VIII

4.

Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot